We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.76B
AUM Growth
-$256M
Cap. Flow
-$351M
Cap. Flow %
-19.91%
Top 10 Hldgs %
49.94%
Holding
89
New
12
Increased
13
Reduced
24
Closed
14

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$19.2M
2
INSP icon
Inspire Medical Systems
INSP
+$17.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$12.3M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12M
5
WAT icon
Waters Corp
WAT
+$9.94M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$39.7M
2
DXCM icon
DexCom
DXCM
+$26.2M
3
EW icon
Edwards Lifesciences
EW
+$25.4M
4
BSX icon
Boston Scientific
BSX
+$18.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$18.8M

Sector Composition

Rank Sector Weight
1 Healthcare 95.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOH icon
26
Molina Healthcare
MOH
$10.2B
$24.1M 1.37%
70,088
– –
XBI icon
27
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$21.6M 1.22%
218,200
-376,300
-63% -$37M
INSP icon
28
Inspire Medical Systems
INSP
$1.5B
$20.8M 1.18%
+98,322
New +$17.1M
WAT icon
29
Waters Corp
WAT
$36.8B
$18.4M 1.04%
51,063
+30,522
+149% +$9.94M
OSCR icon
30
Oscar Health
OSCR
$9.27B
$18.3M 1.03%
860,821
– –
EPIX
31
DELISTED
ESSA Pharma
EPIX
$16.6M 0.94%
2,742,936
-222,506
-8% -$1.22M
ASND icon
32
Ascendis Pharma A/S
ASND
$16B
$13.6M 0.77%
+90,766
New +$12.3M
ERAS icon
33
Erasca
ERAS
$6.19B
$13.3M 0.75%
4,876,911
+205,137
+4% +$578K
XBI icon
34
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$12M 0.68%
+121,845
New +$12M
INSM icon
35
Insmed
INSM
$21.3B
$11.1M 0.63%
152,228
-89,087
-37% -$6.57M
SRPT icon
36
Sarepta Therapeutics
SRPT
$1.68B
$11M 0.62%
88,216
– –
CELC icon
37
Celcuity
CELC
$4.28B
$10.6M 0.6%
710,255
-126,747
-15% -$2.09M
PRAX icon
38
Praxis Precision Medicines
PRAX
$8.52B
$10.5M 0.6%
183,092
-270,054
-60% -$14.6M
ADAP
39
DELISTED
Adaptimmune Therapeutics
ADAP
$9.5M 0.54%
10,000,787
-519,444
-5% -$589K
BSX icon
40
Boston Scientific
BSX
$72B
$9.09M 0.52%
108,469
-239,638
-69% -$18.9M
CRBU icon
41
Caribou Biosciences
CRBU
$149M
$8.44M 0.48%
4,306,671
+223,299
+5% +$457K
SNDX icon
42
Syndax Pharmaceuticals
SNDX
$1.7B
$8.16M 0.46%
423,910
+36,553
+9% +$755K
HOWL icon
43
Werewolf Therapeutics
HOWL
$17.9M
$7.21M 0.41%
3,398,747
+157,673
+5% +$359K
XENE icon
44
Xenon Pharmaceuticals
XENE
$6.02B
$7.08M 0.4%
179,878
+29,324
+19% +$1.18M
CON
45
Concentra Group Holdings
CON
$4.06B
$6.71M 0.38%
+300,000
New +$6.93M
KROS icon
46
Keros Therapeutics
KROS
$200M
$5.87M 0.33%
101,050
+67,695
+203% +$3.34M
ALKS icon
47
Alkermes
ALKS
$8.31B
$5.74M 0.33%
205,073
– –
ITCI
48
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.66M 0.32%
77,387
-93,013
-55% -$6.99M
TGTX icon
49
TG Therapeutics
TGTX
$7.07B
$5.46M 0.31%
+233,410
New +$5.1M
ACLX
50
DELISTED
Arcellx
ACLX
$5.06M 0.29%
60,602
-251,378
-81% -$16.7M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q3 2024 Portfolio in Review

As of Q3 2024, PFM Health Sciences held 89 positions worth $1.76B, down 13% from $2.02B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

PFM Health Sciences withdrew a net $351M in Q3 2024, closing 14 positions and reducing 24 holdings. Its most notable exit was Centene, an estimated $39.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 89% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Inspire Medical Systems worth $20.8M.

  • PFM Health Sciences's largest Q3 2024 buy was Inspire Medical Systems: 98,322 shares worth $20.8M.
  • PFM Health Sciences added most to Acadia Healthcare in Q3 2024, an estimated $19.2M increase.
  • PFM Health Sciences's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $25.4M.
  • PFM Health Sciences fully exited Centene in Q3 2024, selling an estimated $39.7M.
  • PFM Health Sciences's ten largest holdings make up 50% of its $1.76B portfolio in Q3 2024.
  • PFM Health Sciences opened 12 new positions and closed 14 in Q3 2024.
  • PFM Health Sciences's portfolio value fell 13% quarter-over-quarter to $1.76B.

Based on PFM Health Sciences's 13F filing for Q3 2024, filed 14 Nov 2024.